EP3773580 - MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 15.01.2021 Database last updated on 03.09.2024 | |
Former | The international publication has been made Status updated on 05.10.2019 | Most recent event Tooltip | 26.02.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Aerie Pharmaceuticals, Inc. 550 Hills Drive, Third Floor Bedminster, NJ 07921 / US | [2021/07] | Inventor(s) | 01 /
DELONG, Mitchell A. 212 Hillcrest Circle Chapel Hill, NC 27514 / US | 02 /
STURDIVANT, Jill M. 3930 Crawford Dairy Road Chapel Hill, NC 27516 / US | 03 /
LICHOROWIC, Cynthia L. 912 Odyssey Dr. Durham, NC 27713 / US | 04 /
LIN, Cheng-Wen 6424 Reserve Pine Drive Cary, NC 27519 / US | [2021/22] |
Former [2021/07] | 01 /
DELONG, Mitchell A. 212 Hillcrest Circle Chapel Hill, NC 27514 / US | ||
02 /
STURDIVANT, Jill M. 3930 Crawford Dairy Road Chapel Hill, NC 27516 / US | |||
03 /
LICHOROWIC, Cynthia L. 8510 Brittdale Lane, 201 Raleigh, NC 27617 / US | |||
04 /
LIN, Cheng-Wen 6424 Reserve Pine Drive Cary, NC 27519 / US | Representative(s) | K&L Gates LLP Friedrichstraße 110 A 10117 Berlin / DE | [N/P] |
Former [2021/07] | K&L Gates LLP Markgrafenstrasse 42 10117 Berlin / DE | Application number, filing date | 19777599.2 | 29.03.2019 | [2021/07] | WO2019US24954 | Priority number, date | US201862650687P | 30.03.2018 Original published format: US 201862650687 P | [2021/07] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019191654 | Date: | 03.10.2019 | Language: | EN | [2019/40] | Type: | A1 Application with search report | No.: | EP3773580 | Date: | 17.02.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 03.10.2019 takes the place of the publication of the European patent application. | [2021/07] | Search report(s) | International search report - published on: | US | 03.10.2019 | (Supplementary) European search report - dispatched on: | EP | 20.01.2022 | Classification | IPC: | A61K31/47, C07D217/22, A61K9/00 | [2022/08] | CPC: |
A61P27/02 (EP,CN,IL,KR,US);
C07D217/04 (EP,IL,US);
C07D217/22 (KR);
C07D217/02 (CN);
A61K31/472 (CN,KR);
A61K9/0048 (IL,KR,US);
A61K9/0051 (EP);
A61P25/28 (CN);
A61P27/06 (EP,CN,IL,KR,US);
A61P29/00 (EP,CN,IL,US);
A61P3/10 (CN);
A61P9/12 (CN);
C07C309/25 (CN);
C07C309/29 (CN);
C07C309/30 (CN,IL,US);
C07C309/32 (CN);
C07C309/39 (CN);
C07B2200/07 (CN);
C07B2200/13 (IL,US)
(-)
|
Former IPC [2021/07] | A61K31/47, C07D217/22 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/07] | Title | German: | MONO-( SÄURE)SALZE VON 6-AMINOISOCHINOLINEN UND DEREN VERWENDUNGEN | [2021/07] | English: | MONO-(ACID) SALTS OF 6-AMINOISOQUINOLINES AND USES THEREOF | [2021/07] | French: | SELS DE MONO-(ACIDE) DE 6-AMINOISOQUINOLINES ET LEURS UTILISATIONS | [2021/07] | Entry into regional phase | 27.10.2020 | National basic fee paid | 27.10.2020 | Search fee paid | 27.10.2020 | Designation fee(s) paid | 27.10.2020 | Examination fee paid | Examination procedure | 27.10.2020 | Examination requested [2021/07] | 16.08.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.10.2020 | Renewal fee patent year 03 | 25.03.2022 | Renewal fee patent year 04 | 27.02.2023 | Renewal fee patent year 05 | 26.02.2024 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US2010004239 (TANG PENG CHO [CN], et al) [Y] 2, 19/2, 35/2, 36/35/2, 37/36/35/2, 48/35/2, 49/2, 50/49/2, 51/49/2, 52/49/2, 53/52/49/2, 54/52/49/2, 55/2, 58/2, 59/58/2, 60/59/58/2, 61/2, 62/2 * ; paragraphs [0027], [0040], [0152] *; | [XY]US2018050990 (STURDIVANT JILL M [US], et al) [X] 1, 4-8, 19-/1, 19/4-8, 35/1, 35/4-8, 36/35/1, 36/35/4-8, 37/36/35/1, 37/36/35/4-8 48/35/1, 48/35/4-8, 49/1, 49/4-8, 50/49/1, 50/49/4-8, 51/49/1, 51/49/4-8, 52/49/1, 52/49/4-8, 53/52/49/1, 53/52/49/4-8, 54/52/49/1, 54/52/49/4-8, 55/1, 55/4-8, 58/1, 58/4-8, 59/58/1, 59/58/4-8, 60/59/58/1, 60/59/58/4-8, 61/1, 61/4-8, 62/1, 62/4-8 * ; paragraphs [0008]-[0010], [0037], [0039], [0041], [0045], [0047], [0056], [0059], [0075], [0094], [0121], [0140], [0149] * [Y] 2, 19/2, 35/2, 36/35/2, 37/36/35/2, 48/35/2, 49/2, 50/49/2, 51/49/2, 52/49/2, 53/52/49/2, 54/52/49/2, 55/2, 58/2, 59/58/2, 60/59/58/2, 61/2, 62/2; | [A] - DONEGAN, RK et al., "Discovery of molecular therapeutics for glaucoma: Challenges, successes, and promising directions", Journal of Medicinal Chemistry, (20160211), vol. 59, no. 3, pages 788 - 809, XP055640474 [A] 1 * , re-numbered 1-44; page compound R-13 * DOI: http://dx.doi.org/10.1021/acs.jmedchem.5b00828 |